Emily A Bernhardt

Array ( [id] => 3696550 [patent_doc_number] => 05650521 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Pyrrolidine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/580607 [patent_app_country] => US [patent_app_date] => 1995-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7288 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650521.pdf [firstpage_image] =>[orig_patent_app_number] => 580607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3724624 [patent_doc_number] => 05681843 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Parabanic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 8/575024 [patent_app_country] => US [patent_app_date] => 1995-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10986 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681843.pdf [firstpage_image] =>[orig_patent_app_number] => 575024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3709136 [patent_doc_number] => 05654472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Triazole derivatives' [patent_app_type] => 1 [patent_app_number] => 8/553558 [patent_app_country] => US [patent_app_date] => 1995-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19865 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654472.pdf [firstpage_image] =>[orig_patent_app_number] => 553558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938239 [patent_doc_number] => 05972971 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Fungicidal active compound combinations' [patent_app_type] => 1 [patent_app_number] => 8/564249 [patent_app_country] => US [patent_app_date] => 1995-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4021 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972971.pdf [firstpage_image] =>[orig_patent_app_number] => 564249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3878947 [patent_doc_number] => 05804595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Kappa opioid receptor agonists' [patent_app_type] => 1 [patent_app_number] => 8/567624 [patent_app_country] => US [patent_app_date] => 1995-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12272 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804595.pdf [firstpage_image] =>[orig_patent_app_number] => 567624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648612 [patent_doc_number] => 05684026 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Aminocyclopentane derivative' [patent_app_type] => 1 [patent_app_number] => 8/561947 [patent_app_country] => US [patent_app_date] => 1995-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11572 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684026.pdf [firstpage_image] =>[orig_patent_app_number] => 561947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636760 [patent_doc_number] => 05631392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Hydroformylation process and bidentate phosphite ligand catalysts used therein' [patent_app_type] => 1 [patent_app_number] => 8/559807 [patent_app_country] => US [patent_app_date] => 1995-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4878 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631392.pdf [firstpage_image] =>[orig_patent_app_number] => 559807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3829039 [patent_doc_number] => 05739114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Immunosuppressive cyclolignan derivatives' [patent_app_type] => 1 [patent_app_number] => 8/558127 [patent_app_country] => US [patent_app_date] => 1995-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1420 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739114.pdf [firstpage_image] =>[orig_patent_app_number] => 558127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876019 [patent_doc_number] => 05747420 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Tetrazolinones' [patent_app_type] => 1 [patent_app_number] => 8/552900 [patent_app_country] => US [patent_app_date] => 1995-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21705 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747420.pdf [firstpage_image] =>[orig_patent_app_number] => 552900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3841452 [patent_doc_number] => 05847184 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Process for preparing phosphorus-containing dicarboxylic acids' [patent_app_type] => 1 [patent_app_number] => 8/532114 [patent_app_country] => US [patent_app_date] => 1995-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2097 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/847/05847184.pdf [firstpage_image] =>[orig_patent_app_number] => 532114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3746192 [patent_doc_number] => 05716944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Phosphonic acid compounds, their production and use' [patent_app_type] => 1 [patent_app_number] => 8/501022 [patent_app_country] => US [patent_app_date] => 1995-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19729 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 819 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716944.pdf [firstpage_image] =>[orig_patent_app_number] => 501022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623078 [patent_doc_number] => 05594023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => '1,3-dihydroindol-2-one derivatives substituted in the 3-position by a nitrogen-containing group, their preparation and the pharmaceutical compositions in which they are present' [patent_app_type] => 1 [patent_app_number] => 8/500924 [patent_app_country] => US [patent_app_date] => 1995-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63073 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/594/05594023.pdf [firstpage_image] =>[orig_patent_app_number] => 500924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591774 [patent_doc_number] => 05585499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Cyclopropylbenzindole-containing cytotoxic drugs' [patent_app_type] => 1 [patent_app_number] => 8/469891 [patent_app_country] => US [patent_app_date] => 1995-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 12453 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 276 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585499.pdf [firstpage_image] =>[orig_patent_app_number] => 469891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3829541 [patent_doc_number] => 05739148 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => '6-(2-Imidazolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists' [patent_app_type] => 1 [patent_app_number] => 8/496704 [patent_app_country] => US [patent_app_date] => 1995-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9229 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739148.pdf [firstpage_image] =>[orig_patent_app_number] => 496704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3950436 [patent_doc_number] => 05955491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Method for treating osteoporosis' [patent_app_type] => 1 [patent_app_number] => 8/495352 [patent_app_country] => US [patent_app_date] => 1995-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 22131 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 1662 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955491.pdf [firstpage_image] =>[orig_patent_app_number] => 495352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3833259 [patent_doc_number] => 05739396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Asymmetric ligands useful for transition metal catalyzed bond forming reactions' [patent_app_type] => 1 [patent_app_number] => 8/487039 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10994 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739396.pdf [firstpage_image] =>[orig_patent_app_number] => 487039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4160357 [patent_doc_number] => 06114544 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Optically active fluorinated compounds' [patent_app_type] => 1 [patent_app_number] => 8/470467 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3345 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114544.pdf [firstpage_image] =>[orig_patent_app_number] => 470467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009405 [patent_doc_number] => 05889044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-30 [patent_title] => 'Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity' [patent_app_type] => 1 [patent_app_number] => 8/454890 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8240 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/889/05889044.pdf [firstpage_image] =>[orig_patent_app_number] => 454890 [rel_patent_id] =>[rel_patent_doc_number] =>)